Overview
Retatrutide is a investigational triple-agonist peptide used in metabolic research to examine activity across GLP-1, GIP, and glucagon receptor pathways.
Research Focus
Laboratory use focuses on multi-agonist receptor models, signaling integration, and incretin-related biochemical processes.
Mechanism of Interest
Its triple-agonist profile supports research into receptor crosstalk, intracellular signal transduction, and metabolic pathway mapping.
Compliance Notice
For research only. Not for human consumption.
top of page
$200.00Price
All products offered are solely for research and development purposes, not for human or animal consumption, medical, or therapeutic applications. Our products should not be misconstrued or substituted as prescription drugs. We do not dispense any prescription medications and are not a pharmacy. The US Food and Drug Administration has not assessed the assertions made on our website. Products are not intended to diagnose, treat, cure, or prevent any medical conditions or diseases.
bottom of page
